ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,455,126 | +46.1% | 11,096 | +15.8% | 0.01% | +42.9% |
| Q2 2023 | $3,732,834 | -7.9% | 9,578 | -11.9% | 0.01% | -12.5% |
| Q1 2023 | $4,051,435 | -4.5% | 10,874 | -2.9% | 0.01% | -11.1% |
| Q4 2022 | $4,241,381 | +26.6% | 11,196 | +18.0% | 0.01% | +28.6% |
| Q3 2022 | $3,349,000 | +29.9% | 9,486 | +39.4% | 0.01% | +16.7% |
| Q2 2022 | $2,578,000 | +130.8% | 6,803 | +92.0% | 0.01% | +200.0% |
| Q1 2022 | $1,117,000 | +31.4% | 3,544 | +46.0% | 0.00% | 0.0% |
| Q4 2021 | $850,000 | – | 2,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |